Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
IL4Rα blockade inhibits proliferation of malignant lymphocytes and the immunosuppressive tumor microenvironment of mycosis fungoides.
Journal: Journal for immunotherapy of cancer
Published: May 16, 2026
Caution in Interpreting Retrospective Comparisons of Acitretin and Bexarotene in Mycosis Fungoides.
Journal: The British journal of dermatology
Published: March 13, 2026
When lesions become states: Spatial and temporal immune mismatch in mycosis fungoides.
Journal: The Journal of investigative dermatology
Published: March 11, 2026
The immune ensemble behind mogamulizumab-associated rash.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 10, 2026
Dermatopathological Challenges in Objectively Characterizing Immunotherapy Response in Mycosis Fungoides.
Journal: Dermatopathology (Basel, Switzerland)
Published: May 15, 2025
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab.
Journal: The Journal of dermatological treatment
Published: February 02, 2025
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 19, 2024
The odyssey of diagnosis of mycosis fungoides: Sailing beyond clonality and histology.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 22, 2024
Maintenance therapy for CTCL: importance for prevention of disease progression.
Journal: Leukemia & lymphoma
Published: July 08, 2024
A Retrospective Cohort Study to Determine Real-World Treatment Patterns in Patients with Sézary Syndrome in the United States.
Journal: Oncology and therapy
Published: June 11, 2024
Last Updated: 09/26/2026